Module IX - A Review of Serotonin Syndrome and Neuroleptic Malignant Syndrome

Saturday November 28, 1998 - Question 8

Which of the following statements regarding neuroleptic malignant syndrome (NMS) is correct?

A. Neuroleptic malignant syndrome is a rare complication of neuroleptic treatment.
B. The condition is characterized by a hypometabolic state.
C. This syndrome is only associated with phenothiazine neuroleptic treatment.
D. Neuroleptic malignant syndrome has not yet been reported in non-psychotic patients receiving neuroleptics.
E. Neuroleptic malignant syndrome is more likely to occur during the chronic phase of psychiatric illness in persons stabilized on a medication regimen.
 
 

Discussion